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We describe a case of bacteremia due to an as yet unclassified Acinetobacter genomic species 17-like strain.
The recognition of this microorganism as non-Acinetobacter baumannii may have important epidemiological
implications, as it relieves the hospital of the implementation of barrier precautions for patients infected or
colonized as may be necessary with a multiresistant A. baumannii epidemic.
CASE REPORT
A 49-year-old man was admitted to a hospital in Barcelona
(Spain) on 29 July 2000 because of L2-L3-L4 vertebral frac-
tures as a consequence of a car accident. The patient was a
heavy smoker (60 cigarettes a day) and consumed 20 g of
alcohol daily. Several days later, renal insufficiency, ascites, and
generalized edema developed. A diagnosis of hepatic insuffi-
ciency (probably related to alcoholic liver disease) with hepa-
torenal syndrome was made. On deterioration of the condition
of the patient 1 month later, he was transferred to Hospital
Bellvitge, also in Barcelona, where repeated paracenteses were
performed and intravenous albumin administered, with
some improvement. During hospitalization, the patient re-
ceived piperacillin-tazobactam for primary bacteremia due to
Pseudomonas aeruginosa over 15 days and ceftriaxone as em-
pirical treatment for a low-grade fever, which was discontinued
after negative blood cultures were obtained. Sixty days after
admission, the patient presented an acute picture of fever
with chills and hypotension, without focal signs or symp-
toms. Piperacillin-tazobactam was again started, a peripheral
catheter (that had been in place for 8 days) was removed, and
hemodialysis was begun due to worsened renal insufficiency. Two
consecutive blood cultures were processed with an interval of
2 h. Both blood cultures yielded a gram-negative rod that was
identified as Acinetobacter baumannii in the local laboratory and
Acinetobacter genomic species 17 by amplified ribosomal DNA
restriction analysis (ARDRA) (5) and 16S rRNA gene se-
quence analysis. However, the genomic fingerprint obtained
by amplified fragment length polymorphism (AFLP) analysis
could not be identified by comparison to those of 200
reference strains (see below). Ceftriaxone was substituted
for piperacillin-tazobactam, as the organism was susceptible to
the former. The bacteremic episode was resolved. Renal bi-
opsy showed a diagnosis of immunoglobulin A mesangial glo-
merulonephritis with extracapillary reaction. The patient was
discharged 5 months after admission. He died 2 months later
as a consequence of liver failure with metabolic encephalopa-
thy and gastrointestinal bleeding.
The genus Acinetobacter has a complex taxonomy with up to
32 described named and unnamed genomic species (3, 14, 16).
Reliable identification of Acinetobacter strains to species level
is difficult and requires the use of molecular methods or a
combination of genotypic and phenotypic methods (14). The
species most frequently isolated from clinical samples are A.
baumannii and Acinetobacter genomic species 3 and 13TU
which, together with the environmental species Acinetobacter
calcoaceticus, are combined in the so-called A. calcoaceticus-A.
baumannii complex. The epidemiology and clinical relevance
of Acinetobacter baumannii has been extensively studied (1),
but there is scarce information about the epidemiology and
clinical relevance of other, rarely isolated species. This is partly
due to the lack of easy methods for species identification. Here
we describe a case of bacteremia due to a strain identified by
16S rRNA gene sequence analysis as Acinetobacter genomic
species 17-like but which could not be classified to any species
by AFLP analysis.
The strain (Ac209, LUH8320) was sent to the reference
laboratory (Hospital Clinic, Barcelona, Spain) for possible in-
clusion in the GEIH Ab-2000 project, a nationwide cohort
study of all cases of A. baumannii colonization or infections in
Spain performed during November 2000. The specific meth-
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odology of the study and some results have been published
elsewhere (8, 17). In the Laboratory of Microbiology of the
Hospital Clinic in Barcelona, Spain, and in the Department of
Infectious Diseases of the Leiden University Medical Center,
the strain was identified as an unnamed genomic species 17
using ARDRA. The profile, consisting of the combination of
restriction patterns 1, 2, 1, 2, and 3 generated with the respec-
tive enzymes CfoI, AluI, MboI, RsaI, and MspI, together with
BsmAI pattern 2 and with BfaI pattern 4, identified the organ-
ism as Acinetobacter genomic species 17 strains. With 16S
rRNA gene sequence analysis, the microorganisms had a se-
quence similarity of 99.09% to Acinetobacter genomic species
17. With the high-resolution genomic fingerprinting analysis
using AFLP, the isolate did not cluster at or above the 50%
level with the reference strains of any described (genomic)
species and was thus considered an as yet undescribed species
(15). Further phenotypic studies were performed according to
the method of Bouvet and Grimont (4) with minor modifica-
tions (14). The strain showed hemolytic activity and produced
gelatinase, while it did not acidify Hugh-Leifson medium with
D-glucose. It grew at 37°C but not at 44°C in brain heart
infusion broth. Its carbon source utilization profile was differ-
ent from those of all of the 32 Acinetobacter strains described
(5, 6, 8, 14). The most notable feature was its ability to grow on
histamine, a feature reported so far only in strains of the nonpro-
teolytic genomic species 10 and 11 (4), proteolytic genomic spe-
cies 14TU (9), and an as yet unclassified proteolytic strain (5). In
addition, it did not utilize DL-lactate and 4-aminobutyrate (5),
thereby distinguishing it from genomic species 17.
Antimicrobial susceptibility testing was performed by mi-
crodilution following the guidelines established by the CLSI
(formerly NCCLS) (13). The antimicrobial agents used were
ampicillin, piperacillin, cefoxitin, cephalothin, ceftazidime,
cefepime, sulbactam, ampicillin plus sulbactam, imipenem,
meropenem, ciprofloxacin, gentamicin, tobramycin, amikacin,
doxycycline, and polymyxin B. Pseudomonas aeruginosa ATCC
27853 was used as a control strain.
Most Acinetobacter bacteremias are caused by A. baumannii.
However, some cases may be caused by other species. Bacte-
remia due to Acinetobacter genomic species 13TU (12), Acineto-
bacter junii (10), and Acinetobacter ursingii (11) (identified by
molecular methods) have been described. In the present
study, a severe clinical case of an as yet unclassified hemo-
lytic Acinetobacter strain is described; this case presented as a
primary bacteremia with clinical evidence of sepsis in a predis-
posed patient. The infection responded to antibiotic therapy
and removal of a venous catheter (which was the suspected
origin of the bacteremia).
Correct identification of Acinetobacter species is relevant for
therapeutic reasons, as species other than A. baumannii are
generally susceptible to more antimicrobial agents. The micro-
organism of the present study was susceptible to all the anti-
microbial agents tested except for cefoxitin and cephalothin,
while a slightly elevated MIC of polymyxin B (2 mg/liter) was
observed. Moreover, the recognition of this microorganism as
non-A. baumannii may have important epidemiological impli-
cations, as it relieves the hospital from implementation of
barrier precautions that might be necessary with a multiresis-
tant A. baumannii epidemic.
The organism was identified by the widely used commercial
API20NE system as A. baumannii, while 16S rRNA gene anal-
ysis identified the organism as similar to the unnamed genomic
species 17. This emphasizes that correct identification of Acineto-
bacter species, according to the current taxonomy, is problem-
atic. The problems of phenotypic identification of acineto-
bacters has been documented (2, 9), but the usefulness of 16S
rRNA gene sequence analysis has not been evaluated yet. In
addition, ARDRA profiles, which are essentially based on the
16S sequence, are not always conclusive, since some profiles
may occur in different species (7). AFLP fingerprint analysis,
using the Leiden University AFLP library of 200 reference
strains of all described species, did not identify the strain as any
of the 32 species of Acinetobacter described. These problems
underscore the problem of correct identification of Acineto-
bacter species in the diagnostic laboratory.
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